Kanion Pharmaceutical (China)

579 papers and 10.1k indexed citations i.

About

In recent decades, authors affiliated with Kanion Pharmaceutical (China) have published 579 papers, which have received a total of 10.1k indexed citations. Scholars at this organization have produced 286 papers in Molecular Biology, 159 papers in Complementary and alternative medicine and 122 papers in Pharmacology on the topics of Natural product bioactivities and synthesis (88 papers), Traditional Chinese Medicine Analysis (88 papers) and Phytochemistry and Biological Activities (67 papers). Their work is cited by papers focused on Molecular Biology (4.8k citations), Pharmacology (1.9k citations) and Complementary and alternative medicine (1.7k citations). Authors at Kanion Pharmaceutical (China) collaborate with scholars in China, United States and Australia and have published in prestigious journals including Angewandte Chemie International Edition, Journal of Clinical Oncology and PLoS ONE. Some of Kanion Pharmaceutical (China)'s most productive authors include Wei Xiao, Zhenzhong Wang, Gang Ding, Liang Cao, Linguo Zhao, Wei Xiao, Wenzhe Huang, Qian Zhao, Jianjun Pei and Lin Ge.

In The Last Decade

Fields of papers published by authors at Kanion Pharmaceutical (China)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Kanion Pharmaceutical (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Kanion Pharmaceutical (China) at the time of their publication.

Countries citing scholars working at Kanion Pharmaceutical (China)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Kanion Pharmaceutical (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Kanion Pharmaceutical (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanion Pharmaceutical (China) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025